Uncategorized
Featured Stories
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
Forging the Future of Chronic Care: 3 Ways Tech is Helping Transform the Patient Experience
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
California Senate Proclaims November 7-13 as CKD Education Week
DENVER, Nov 04, 2010 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced the California…
-
DaVita 3rd Quarter 2010 Results
DENVER, Nov 04, 2010 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2010. Net income attributable to DaVita Inc. for the three months ended…
-
DaVita Inc. Announces Signing of New $3 Billion Secured Credit Agreement
DENVER, Oct 20, 2010 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA) (“DaVita” or the “Company”) today announced the signing of a new $3 billion senior secured credit agreement. The credit agreement…
-
DaVita Inc. Announces Results as of Consent Payment Deadline and Execution of Supplemental Indentures Related to Its 6 5/8% Senior Notes Due 2013 and 7 1/4% Senior Subordinated Notes Due 2015
DENVER, Oct 15, 2010 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA) (“DaVita” or the “Company”) today announced the execution of supplemental indentures related to its previously announced consent…
-
DaVita Inc. Announces Pricing of $1.55 Billion Senior Notes
DENVER, Oct 05, 2010 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA) (“DaVita” or the “Company”) announced today the pricing of $775 million principal amount of 6 3/8% Senior Notes due 2018 (the “2018…